サマリー

市場分析と洞察。CAR T-Cell Therapyの世界市場
COVID-19のパンデミックにより、CAR T-Cell Therapyの世界市場規模は2022年に2億8,058万米ドル相当と推定され、2022年から2028年までの予測期間にCAGR29.94%で、2028年までに1,3503万米ドルに再調整されると予測されています。
CAR T細胞療法の世界の主要メーカーは、Novartis、Gilead Sciences、Bristol-Myers Squibb、J & J、JW Therapeutics、FOSUNKiteなどです。収益面では、2021年のCAR T-Cell Therapyの市場シェアは、世界3大企業が99.32％を占めています。

業界標準の分析精度と高いデータ完全性を備えた本レポートは、世界のCAR T-Cell Therapy市場で利用可能な主要機会を明らかにし、プレイヤーが市場で強力な地位を獲得するのに役立つ素晴らしい試みを行っています。本レポートの購入者は、世界のCAR T-Cell Therapy市場の全体規模（収益ベース）を含む、検証済みで信頼できる市場予測にアクセスすることができます。
全体として、本レポートは、プレイヤーが競合他社に対する競争力を獲得し、世界のCAR T-Cell Therapy市場で持続的な成功を収めるために使用できる効果的なツールであることが証明されています。本レポートで提供されるすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証され、再確認されたものです。本レポートを執筆したアナリストは、世界のCAR T-Cell Therapy市場を詳細に調査するため、独自の業界最高水準の調査・分析アプローチを採用しています。

世界のCAR T-Cell Therapyの範囲と市場規模
CAR T-Cell Therapyの市場は、プレイヤー、地域（国）、タイプ、用途別に分類されます。CAR T-Cell Therapyの世界市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるようになります。セグメント別分析では、2017-2028年の期間において、タイプ別の収益と予測、アプリケーション別の収益と予測に焦点を当てます。

企業別
ノバルティス
ギリアド・サイエンス
ブリストル・マイヤーズ スクイブ
J＆J社
JWセラピューティック
FOSUNKite
CARsgenセラピューティック（パイプライン）
オートラス・セラピューティック（パイプライン）
ソレント・セラピューティック（パイプライン）
ムスタングバイオ(パイプライン)
ブルーバードバイオ(パイプライン)
セレクティス（パイプライン）
アロジーン・セラピューティック（パイプライン）
セリード(パイプライン)

タイプ別セグメント
CD19ターゲット
BCMAターゲット

アプリケーション別セグメント
リンパ腫
多発性骨髄腫

地域別
北アメリカ
米国
カナダ
メキシコ
アジア・パシフィック
中国
日本
韓国
インド
その他のアジア
欧州
ドイツ
フランス
英国
イタリア
ロシア
その他の欧州
南米
ブラジル
南米のその他
中近東・アフリカ
中近東
アフリカ

ページTOPに戻る

目次

1 REPORT OVERVIEW 1
1.1 Study Scope 1
1.2 Market Analysis by Type 2
1.2.1 Global CAR T-Cell Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 2
1.2.2 CD19-targeted 3
1.2.3 BCMA-targeted 4
1.3 Market by Application 5
1.3.1 Global CAR T-Cell Therapy Market Share by Application: 2017 VS 2021 VS 2028 6
1.3.2 Lymphoma 7
1.3.3 Multiple Myeloma 8
1.4 Study Objectives 9
1.5 Years Considered 10
2 GLOBAL GROWTH TRENDS 11
2.1 Global CAR T-Cell Therapy Market Perspective (2017-2028) 11
2.2 CAR T-Cell Therapy Growth Trends by Region 12
2.2.1 CAR T-Cell Therapy Market Size by Region: 2017 VS 2021 VS 2028 12
2.2.2 CAR T-Cell Therapy Historic Market Size by Region (2017-2022) 13
2.2.3 CAR T-Cell Therapy Forecasted Market Size by Region (2023-2028) 14
2.3 CAR T-Cell Therapy Market Dynamics 15
2.3.1 CAR T-Cell Therapy Industry Trends 15
2.3.2 CAR T-Cell Therapy Market Drivers 16
2.3.3 CAR T-Cell Therapy Market Challenges 16
2.3.4 CAR T-Cell Therapy Market Restraints 17
2.3.5 Analysis of Entry Barrier CAR T-Cell Therapy on Global Market and China Market 17
2.4 Market Ecosystem and Value Chain Analysis 18
3 COMPETITION LANDSCAPE BY KEY PLAYERS 20
3.1 Global Top CAR T-Cell Therapy Players by Revenue 20
3.1.1 Global Top CAR T-Cell Therapy Players by Revenue (2017-2022) 20
3.1.2 Global CAR T-Cell Therapy Revenue Market Share by Players (2017-2022) 20
3.2 Global CAR T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 21
3.3 Players Covered: Ranking by CAR T-Cell Therapy Revenue 22
3.4 Global CAR T-Cell Therapy Market Concentration Ratio 22
3.4.1 Global CAR T-Cell Therapy Market Concentration Ratio (CR5 and HHI) 22
3.4.2 Global Top 5 Companies by CAR T-Cell Therapy Revenue in 2021 24
3.5 CAR T-Cell Therapy Key Players Head office and Area Served 24
3.6 Key Players CAR T-Cell Therapy Product Solution and Service 24
3.7 Date of Enter into CAR T-Cell Therapy Market 25
3.8 Mergers & Acquisitions, Expansion Plans 25
4 CAR T-CELL THERAPY BREAKDOWN DATA BY TYPE 28
4.1 Global CAR T-Cell Therapy Historic Market Size by Type (2017-2022) 28
4.2 Global CAR T-Cell Therapy Forecasted Market Size by Type (2023-2028) 28
5 CAR T-CELL THERAPY BREAKDOWN DATA BY APPLICATION 30
5.1 Global CAR T-Cell Therapy Historic Market Size by Application (2017-2022) 30
5.2 Global CAR T-Cell Therapy Forecasted Market Size by Application (2023-2028) 30
6 NORTH AMERICA 32
6.1 North America CAR T-Cell Therapy Market Size (2017-2028) 32
6.2 North America CAR T-Cell Therapy Market Size by Type 32
6.2.1 North America CAR T-Cell Therapy Market Size by Type (2017-2022) 32
6.2.2 North America CAR T-Cell Therapy Market Size by Type (2023-2028) 33
6.2.3 North America CAR T-Cell Therapy Market Share by Type (2017-2028) 33
6.3 North America CAR T-Cell Therapy Market Size by Application 33
6.3.1 North America CAR T-Cell Therapy Market Size by Application (2017-2022) 33
6.3.2 North America CAR T-Cell Therapy Market Size by Application (2023-2028) 34
6.3.3 North America CAR T-Cell Therapy Market Share by Application (2017-2028) 34
6.4 North America CAR T-Cell Therapy Market Size by Country 35
6.4.1 North America CAR T-Cell Therapy Market Size by Country (2017-2022) 35
6.4.2 North America CAR T-Cell Therapy Market Share by Country (2023-2028) 35
6.4.3 United States 36
6.4.4 Canada 37
6.4.5 Mexico 37
7 EUROPE 38
7.1 Europe CAR T-Cell Therapy Market Size (2017-2028) 38
7.2 Europe CAR T-Cell Therapy Market Size by Type 38
7.2.1 Europe CAR T-Cell Therapy Market Size by Type (2017-2022) 38
7.2.2 Europe CAR T-Cell Therapy Market Size by Type (2023-2028) 39
7.2.3 Europe CAR T-Cell Therapy Market Share by Type (2017-2028) 39
7.3 Europe CAR T-Cell Therapy Market Size by Application 39
7.3.1 Europe CAR T-Cell Therapy Market Size by Application (2017-2022) 39
7.3.2 Europe CAR T-Cell Therapy Market Size by Application (2023-2028) 40
7.3.3 Europe CAR T-Cell Therapy Market Share by Application (2017-2028) 40
7.4 Europe CAR T-Cell Therapy Market Size by Country 41
7.4.1 Europe CAR T-Cell Therapy Market Size by Country (2017-2022) 41
7.4.2 Europe CAR T-Cell Therapy Market Size by Country (2023-2028) 41
7.4.3 Germany 42
7.4.4 France 43
7.4.5 U.K. 43
7.4.6 Italy 44
8 ASIA-PACIFIC 45
8.1 Asia-Pacific CAR T-Cell Therapy Market Size (2017-2028) 45
8.2 Asia-Pacific CAR T-Cell Therapy Market Size by Type 45
8.2.1 Asia-Pacific CAR T-Cell Therapy Market Size by Type (2017-2022) 45
8.2.2 Asia-Pacific CAR T-Cell Therapy Market Size by Type (2023-2028) 46
8.2.3 Asia-Pacific CAR T-Cell Therapy Market Share by Type (2019-2028) 46
8.3 Asia-Pacific CAR T-Cell Therapy Market Size by Application 46
8.3.1 Asia-Pacific CAR T-Cell Therapy Market Size by Application (2017-2022) 46
8.3.2 Asia-Pacific CAR T-Cell Therapy Market Size by Application (2023-2028) 47
8.3.3 Asia-Pacific CAR T-Cell Therapy Market Share by Application (2019-2028) 47
8.4 Asia-Pacific CAR T-Cell Therapy Market Size by Region 48
8.4.1 Asia-Pacific CAR T-Cell Therapy Market Size by Region (2017-2022) 48
8.4.2 Asia-Pacific CAR T-Cell Therapy Market Size by Region (2023-2028) 48
8.4.3 China 49
8.4.4 Japan 50
8.4.5 South Korea 50
8.4.6 India 51
9 SOUTH AMERICA 52
9.1 South America CAR T-Cell Therapy Market Size (2017-2028) 52
9.2 South America CAR T-Cell Therapy Market Size by Type 52
9.2.1 South America CAR T-Cell Therapy Market Size by Type (2017-2022) 52
9.2.2 South America CAR T-Cell Therapy Market Size by Type (2023-2028) 53
9.2.3 South America CAR T-Cell Therapy Market Share by Type (2022-2028) 53
9.3 South America CAR T-Cell Therapy Market Size by Application 53
9.3.1 South America CAR T-Cell Therapy Market Size by Application (2017-2022) 53
9.3.2 South America CAR T-Cell Therapy Market Size by Application (2023-2028) 54
9.3.3 South America CAR T-Cell Therapy Market Share by Application (2022-2028) 54
9.4 South America CAR T-Cell Therapy Market Size by Country 55
9.4.1 South America CAR T-Cell Therapy Market Size by Country (2017-2022) 55
9.4.2 South America CAR T-Cell Therapy Market Size by Country (2023-2028) 55
9.4.3 Brazil 56
10 MIDDLE EAST & AFRICA 57
10.1 Middle East & Africa CAR T-Cell Therapy Market Size (2017-2028) 57
10.2 Middle East & Africa CAR T-Cell Therapy Market Size by Type 57
10.2.1 Middle East & Africa CAR T-Cell Therapy Market Size by Type (2017-2022) 57
10.2.2 Middle East & Africa CAR T-Cell Therapy Market Size by Type (2023-2028) 58
10.2.3 Middle East & Africa CAR T-Cell Therapy Market Share by Type (2025-2028) 58
10.3 Middle East & Africa CAR T-Cell Therapy Market Size by Application 59
10.3.1 Middle East & Africa CAR T-Cell Therapy Market Size by Application (2017-2022) 59
10.3.2 Middle East & Africa CAR T-Cell Therapy Market Size by Application (2023-2028) 59
10.3.3 Middle East & Africa CAR T-Cell Therapy Market Share by Application (2025-2028) 60
10.4 Middle East & Africa CAR T-Cell Therapy Market Size by Country 60
10.4.1 Middle East & Africa CAR T-Cell Therapy Market Size by Country (2017-2022) 60
10.4.2 Middle East & Africa CAR T-Cell Therapy Market Size by Country (2023-2028) 61
10.4.3 Middle East 62
10.4.4 Africa 62
11 KEY PLAYERS PROFILES 63
11.1 Novartis 63
11.1.1 Novartis Company Details 63
11.1.2 Novartis Business Overview 63
11.1.3 Novartis CAR T-Cell Therapy Introduction 64
11.1.4 Novartis Revenue in CAR T-Cell Therapy Business (2017-2022) 65
11.1.5 Novartis Recent Development 65
11.2 Gilead Sciences 66
11.2.1 Gilead Sciences Company Details 66
11.2.2 Gilead Sciences Business Overview 67
11.2.3 Gilead Sciences CAR T-Cell Therapy Introduction 67
11.2.4 Gilead Sciences Revenue in CAR T-Cell Therapy Business (2017-2022) 68
11.2.5 Gilead Sciences Recent Development 69
11.3 Bristol-Myers Squibb 70
11.3.1 Bristol-Myers Squibb Company Details 70
11.3.2 Bristol-Myers Squibb Business Overview 70
11.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Introduction 71
11.3.4 Bristol-Myers Squibb Revenue in CAR T-Cell Therapy Business (2017-2022) 72
11.3.5 Bristol-Myers Squibb Recent Development 73
11.4 J & J 74
11.4.1 J & J Company Details 74
11.4.2 J & J Business Overview 74
11.4.3 J & J CAR T-Cell Therapy Introduction 75
11.4.4 J & J Revenue in CAR T-Cell Therapy Business (2017-2022) 76
11.4.5 J & J Recent Development 76
11.5 JW Therapeutics 77
11.5.1 JW Therapeutics Company Details 77
11.5.2 JW Therapeutics Business Overview 77
11.5.3 JW Therapeutics CAR T-Cell Therapy Introduction 78
11.5.4 JW Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022) 79
11.5.5 JW Therapeutics Recent Development 79
11.6 FOSUNKite 80
11.6.1 FOSUNKite Company Details 80
11.6.2 FOSUNKite Business Overview 80
11.6.3 FOSUNKite CAR T-Cell Therapy Introduction 81
11.6.4 FOSUNKite Revenue in CAR T-Cell Therapy Business (2017-2022) 81
11.6.5 FOSUNKite Recent Development 82
11.7 CARsgen Therapeutics (Pipeline) 83
11.7.1 CARsgen Therapeutics Company Details 83
11.7.2 CARsgen Therapeutics Business Overview 83
11.7.3 CARsgen Therapeutics CAR T-Cell Therapy Introduction 84
11.8 Autolus Therapeutics (Pipeline) 84
11.8.1 Autolus Therapeutics Company Details 84
11.8.2 Autolus Therapeutics Business Overview 85
11.8.3 Autolus Therapeutics CAR T-Cell Therapy Introduction 85
11.9 Sorrento Therapeutics (Pipeline) 86
11.9.1 Sorrento Therapeutics Company Details 86
11.9.2 Sorrento Therapeutics Business Overview 87
11.9.3 Sorrento Therapeutics CAR T-Cell Therapy Introduction 87
11.10 Mustang Bio (Pipeline) 87
11.10.1 Mustang Bio Company Details 87
11.10.2 Mustang Bio Business Overview 88
11.10.3 Mustang Bio CAR T-Cell Therapy Introduction 88
11.11 Bluebird Bio (Pipeline) 89
11.11.1 Bluebird Bio Company Details 89
11.11.2 Bluebird Bio Business Overview 89
11.11.3 Bluebird Bio CAR T-Cell Therapy Introduction 90
11.11.4 Bluebird Bio Recent Development 90
11.12 Cellectis (Pipeline) 91
11.12.1 Cellectis Company Details 91
11.12.2 Cellectis Business Overview 91
11.12.3 Cellectis CAR T-Cell Therapy Introduction 92
11.13 Allogene Therapeutics (Pipeline) 92
11.13.1 Allogene Therapeutics Company Details 92
11.13.2 Allogene Therapeutics Business Overview 92
11.13.3 Allogene Therapeutics CAR T-Cell Therapy Introduction 93
11.14 Celyad (Pipeline) 93
11.14.1 Celyad Company Details 93
11.14.2 Celyad Business Overview 94
11.14.3 Celyad CAR T-Cell Therapy Introduction 94
12 ANALYST'S VIEWPOINTS/CONCLUSIONS 95
13 APPENDIX 97
13.1 Methodology/Research Approach 97
13.1.1 Research Programs/Design 97
13.1.2 Market Size Estimation 98
13.1.3 Market Breakdown and Data Triangulation 99
13.2 Data Source 100
13.2.1 Secondary Sources 100
13.2.2 Primary Sources 101
13.3 Author List 103
13.4 Disclaimer 104